{"disease":{"id":"sj-gren-s-syndrome-ss","name":"sj gren s syndrome ss"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06982482","title":"Artificial Intelligence Based Models for Primary Sjögren's Syndrome Diagnosis","phase":"","overall_status":"COMPLETED","enrollment_count":27432,"lead_sponsor_name":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","has_results":false},{"nct_id":"NCT04402086","title":"Rheumatology Patient Registry and Biorepository","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Yale University","has_results":false},{"nct_id":"NCT07188285","title":"Mass Spectrometry-based Immune Profiling in Autoimmune Diseases","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT06245408","title":"A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":434,"lead_sponsor_name":"Amgen","has_results":false},{"nct_id":"NCT05961267","title":"Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism","phase":"","overall_status":"COMPLETED","enrollment_count":318,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT05113004","title":"New Clinical End-points in Patients With Primary Sjögren's Syndrome","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT07180537","title":"Creating Health Course Study for People With Rheumatological Conditions","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Terry L. Wahls","has_results":false},{"nct_id":"NCT06780293","title":"Laser Acupuncture on Dry Eye and Sjögren's Syndrome-related Dry Eye Symptoms (LADESJS)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":140,"lead_sponsor_name":"Taipei Veterans General Hospital, Taiwan","has_results":false},{"nct_id":"NCT01782235","title":"Efficacy of Tocilizumab in Primary Sjögren's Syndrome.","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT04802577","title":"Fatigue in Primary Sjögren's Syndrome","phase":"","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"Bursa Yuksek Ihtisas Training and Research Hospital","has_results":false},{"nct_id":"NCT07145060","title":"A Study of Yiqi Yangyin Formula in the Treatment of Primary Sjogren's Syndrome","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":105,"lead_sponsor_name":"China-Japan Friendship Hospital","has_results":false},{"nct_id":"NCT05715463","title":"Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":101,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT03681964","title":"Diagnostic Suspicion of Primitive Syndrome Sjögren's : Brest Cohort","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT04839315","title":"COVID-19 Vaccination in Rheumatic Disease Patients","phase":"EARLY_PHASE1","overall_status":"TERMINATED","enrollment_count":58,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT06363955","title":"Assessing the Efficacy of a Carbamide Peroxide Mouthwash for Oral Wound Healing, Oral Hygiene and Xerostomia Relief","phase":"NA","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"National and Kapodistrian University of Athens","has_results":false},{"nct_id":"NCT06989411","title":"Current Therapy in Primary Sjogren's Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Pamukkale University","has_results":false},{"nct_id":"NCT06862284","title":"Therapeutic Effect of Upadacitinib in Primary Sjögren's Syndrome","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT05269810","title":"Clinical Study to Investigate the Efficacy of Orally Administered SA001 in Patients With Primary Sjögren's Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Samjin Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06056921","title":"Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Chongqing Precision Biotech Co., Ltd","has_results":false},{"nct_id":"NCT07527936","title":"A Study of BEN301 Injection in theTreatment of Autoimmune Diseases","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":24,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT07123519","title":"A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"China Immunotech (Beijing) Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT07236801","title":"Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"China Immunotech (Beijing) Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT07236762","title":"An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"China Immunotech (Beijing) Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT07526350","title":"MTS109 in Patients With Refractory Autoimmune Diseases","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"Shanghai Changzheng Hospital","has_results":false},{"nct_id":"NCT05859997","title":"Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":15,"lead_sponsor_name":"Bioray Laboratories","has_results":false},{"nct_id":"NCT07413341","title":"A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Therorna","has_results":false},{"nct_id":"NCT06420154","title":"The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":9,"lead_sponsor_name":"First Affiliated Hospital of Wenzhou Medical University","has_results":false},{"nct_id":"NCT06373081","title":"Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":6,"lead_sponsor_name":"Shanghai Changzheng Hospital","has_results":false},{"nct_id":"NCT05217472","title":"An Efficacy and Safety Study of Injectable Ravagalimab to Assess Change in EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) in Adult Participants With Moderately to Severely Active Primary Sjogren's Syndrome (pSS)","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"AbbVie","has_results":false}],"total":29},"guidelines":[],"source":"Drug Landscape verified database"}